ask="4.740"
ask_size="100"
average_daily_volume="31840"
bid="4.400"
bid_size="600"
book_value="1.400"
change="+0.414"
change_from_200_day_moving_average="2.186"
change_from_50_day_moving_average="2.240"
change_from_52_week_high="-0.206"
change_From_52_week_low="2.564"
change_in_percent="+15.564%"
close="3.074"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.300"
ebitda="-2.11M"
eps_estimate_current_year="-0.020"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.020"
ex_dividend_date="N/A"
float_shares="2018000"
high="3.145"
high_52_weeks="3.280"
last_trade_date="2/15/2017"
last_trade_price="3.074"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.670"
low_52_weeks="0.510"
market_capitalization="8.24M"
moving_average_200_day="0.888"
moving_average_50_day="0.834"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="30.000"
open="2.700"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+246.217%"
percent_change_from_50_day_moving_average="+268.403%"
percent_change_from_52_week_high="-6.280%"
percent_change_from_52_week_low="+502.745%"
previous_close="2.660"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.900"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.120"
stock_exchange="NCM"
symbol="XTLB"
volume="89254"
weeks_range_52="0.510 - 3.280"
